168 related articles for article (PubMed ID: 33723514)
1.
Hoffmann MAG; Kieffer C; Bjorkman PJ
Mol Ther Methods Clin Dev; 2021 Jun; 21():161-170. PubMed ID: 33723514
[TBL] [Abstract][Full Text] [Related]
2. [Deep lung--cellular reaction to HIV].
Tavares Marques MA; Alves V; Duque V; Botelho MF
Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
[TBL] [Abstract][Full Text] [Related]
3. CD71
Namdar A; Dunsmore G; Shahbaz S; Koleva P; Xu L; Jovel J; Houston S; Elahi S
mBio; 2019 Nov; 10(6):. PubMed ID: 31772057
[TBL] [Abstract][Full Text] [Related]
4. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.
Glasgow A; Glasgow J; Limonta D; Solomon P; Lui I; Zhang Y; Nix MA; Rettko NJ; Zha S; Yamin R; Kao K; Rosenberg OS; Ravetch JV; Wiita AP; Leung KK; Lim SA; Zhou XX; Hobman TC; Kortemme T; Wells JA
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28046-28055. PubMed ID: 33093202
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
6. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.
Glasgow A; Glasgow J; Limonta D; Solomon P; Lui I; Zhang Y; Nix MA; Rettko NJ; Lim SA; Zha S; Yamin R; Kao K; Rosenberg OS; Ravetch JV; Wiita AP; Leung KK; Zhou XX; Hobman TC; Kortemme T; Wells JA
bioRxiv; 2020 Aug; ():. PubMed ID: 32766586
[TBL] [Abstract][Full Text] [Related]
7. Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip.
Koma T; Yokoyama M; Kotani O; Doi N; Nakanishi N; Okubo H; Adachi S; Adachi A; Sato H; Nomaguchi M
J Virol; 2021 Jun; 95(13):e0217720. PubMed ID: 33883222
[TBL] [Abstract][Full Text] [Related]
8. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.
Alkhatib G; Locati M; Kennedy PE; Murphy PM; Berger EA
Virology; 1997 Aug; 234(2):340-8. PubMed ID: 9268166
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic Correlates of HIV-1 Macrophage Tropism.
Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
[TBL] [Abstract][Full Text] [Related]
11. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
Martín J; LaBranche CC; González-Scarano F
J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
[TBL] [Abstract][Full Text] [Related]
12. Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through
Wang W; Truong K; Ye C; Sharma S; He H; Liu L; Wen M; Misra A; Zhou P; Kimata JT
Front Immunol; 2023; 14():1167965. PubMed ID: 37781368
[TBL] [Abstract][Full Text] [Related]
13. Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
Ao Z; Yu Z; Wang L; Zheng Y; Yao X
PLoS One; 2008 Apr; 3(4):e1995. PubMed ID: 18414671
[TBL] [Abstract][Full Text] [Related]
14. Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.
Zhao C; Princiotto AM; Nguyen HT; Zou S; Zhao ML; Zhang S; Herschhorn A; Farrell M; Pahil K; Melillo B; Sambasivarao SV; Abrams C; Smith AB; Madani N; Sodroski J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391272
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology.
Jenkinson S; McCoy DC; Kerner SA; Ferris RG; Lawrence WK; Clay WC; Condreay JP; Smith CD
J Biomol Screen; 2003 Aug; 8(4):463-70. PubMed ID: 14567799
[TBL] [Abstract][Full Text] [Related]
16. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells.
Hoffmann MAG; Bar-On Y; Yang Z; Gristick HB; Gnanapragasam PNP; Vielmetter J; Nussenzweig MC; Bjorkman PJ
Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18719-18728. PubMed ID: 32690692
[TBL] [Abstract][Full Text] [Related]
18. Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells.
Richard J; Nguyen DN; Tolbert WD; Gasser R; Ding S; Vézina D; Yu Gong S; Prévost J; Gendron-Lepage G; Medjahed H; Gottumukkala S; Finzi A; Pazgier M
mBio; 2021 Oct; 12(5):e0140521. PubMed ID: 34579568
[TBL] [Abstract][Full Text] [Related]
19. Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection.
Speck RF; Penn ML; Wimmer J; Esser U; Hague BF; Kindt TJ; Atchison RE; Goldsmith MA
J Virol; 1998 Jul; 72(7):5728-34. PubMed ID: 9621031
[TBL] [Abstract][Full Text] [Related]
20. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
